| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PGEN | Common Stock | Award | $62.5 K | +43.7 K | +10.19% | $1.43 | 472 K | Mar 14, 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PGEN | Restricted Stock Units | Award | $0 | +87.4 K | $0.00 | 87.4 K | Mar 14, 2024 | Common Stock | 87.4 K | Direct | F2, F3 | ||
| transaction | PGEN | Option to Purchase Common Stock (Right to Buy) | Award | $0 | +102 K | $0.00 | 102 K | Mar 14, 2024 | Common Stock | 102 K | $1.43 | Direct |
| Id | Content |
|---|---|
| F1 | The shares were issued to the reporting person in lieu of an annual retainer of $62,500. |
| F2 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. |
| F3 | The RSUs vest in full on March 14, 2025. |